Free Trial

Xenetic Biosciences (XBIO) Earnings Date, Estimates & Call Transcripts

Xenetic Biosciences logo
$3.08 +0.01 (+0.33%)
Closing price 05/23/2025 03:16 PM Eastern
Extended Trading
$3.07 -0.01 (-0.32%)
As of 05/23/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Xenetic Biosciences Earnings Summary

Xenetic Biosciences announced Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.59, which topped the consensus estimate of -$0.72 by $0.13. Quarterly revenue was reported to be $0.59 million, above analysts' expectations of $0.52 million. With a trailing EPS of -$2.38, Xenetic Biosciences' earnings are expected to grow next year, from ($1.01) to ($0.66) per share.

Upcoming Q2
Earnings Date
Aug. 12Before Market OpensEstimated
Consensus EPS
(May. 13)
-$0.72
Actual EPS
(May. 13)
-$0.59 Beat By $0.13
Actual Revenue
(May. 13)
$0.59M

Q1 2025 Earnings Resources

XBIO Upcoming Earnings

Xenetic Biosciences' next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules.

Get Xenetic Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xenetic Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

XBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Xenetic Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.72-$0.72-$0.72
Q2 20251-$0.64-$0.64-$0.64
Q3 20251-$0.65-$0.65-$0.65
Q4 20251-$0.68-$0.68-$0.68

Xenetic Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2025
(Estimated)
--------
5/13/2025Q1 2025-$0.72-$0.59+$0.13-$0.59$0.52M$0.59M
3/18/2025Q4 2024-$0.20-$0.68 -$0.48-$0.68$0.18M$0.65M
11/12/2024--$0.14-$0.28 -$0.14-$0.28$0.75M$0.61M
8/13/2024--$0.83-$0.83--$0.83$0.54M$0.73M
5/9/2024Q1 2024-$0.79-$0.78+$0.01-$0.78$0.65M$0.51M
3/21/2024Q4 2023-$0.87-$0.77+$0.10-$0.77$0.68M$0.67M
11/10/2023Q3 2023-$1.12-$0.69+$0.43-$0.69$0.46M$0.61M
8/11/2023Q2 2023-$1.13-$0.69+$0.44-$0.69$0.44M$0.65M

Xenetic Biosciences Earnings - Frequently Asked Questions

Xenetic Biosciences (NASDAQ:XBIO) last announced its quarterly earning data on Tuesday, May 13, 2025. Learn more on XBIO's earnings history.

In the previous quarter, Xenetic Biosciences (NASDAQ:XBIO) reported ($0.59) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.72) by $0.13. Learn more on analysts' earnings estimate vs. XBIO's actual earnings.

Xenetic Biosciences (NASDAQ:XBIO) has a recorded annual revenue of $2.58 million.

Xenetic Biosciences (NASDAQ:XBIO) has a recorded net income of -$4.14 million. XBIO has generated -$2.38 earnings per share over the last four quarters.

Xenetic Biosciences's earnings are expected to grow from ($1.01) per share to ($0.66) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:XBIO) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners